Newsletter
Shares of Cupid have surged over the past year, delivering 300%+ returns, driven by a strong order pipeline, expansion plans, and an improving earnings outlook.
What they do: Cupid is a leading Indian maker of sexual wellness products, best known for condoms, lubricants and diagnostic kits, with a focus on sexual health and HIV prevention.
What happened last week: the company’s shares were in the spotlight after hitting a 20% lower circuit on January 2, snapping a 13-day rally after being placed under the surveillance framework.
The stock has since recovered and regained ground, easing concerns after the sharp correction.
The macro scene: a favourable rupee is supporting margins and overseas business. Management sees no material impact from tariffs or trade tensions on FMCG or global B2B expansion.
The global sexual wellness market is set to more than double from $68 billion in 2024 to $156 billion by 2034, growing at nearly 9% rate, creating a strong long-term demand tailwind for Cupid’s core business.
Market Data Forecast
